Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine
Authors
Keywords
Cancer treatment, Metastasis, Metastatic tumors, Mouse models, Tumor resection, Vaccines, T cells, Regulatory T cells
Journal
PLoS One
Volume 10, Issue 10, Pages e0138335
Publisher
Public Library of Science (PLoS)
Online
2015-10-02
DOI
10.1371/journal.pone.0138335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
- (2014) P. Sinha et al. JOURNAL OF IMMUNOLOGY
- Antiangiogenic Therapy Using Sunitinib Combined with Rapamycin Retards Tumor Growth But Promotes Metastasis
- (2014) Tao Yin et al. Translational Oncology
- ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
- (2013) Abhishek D. Garg et al. Autophagy
- SpecificDioscoreaPhytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines
- (2013) Wei-Ting Chang et al. Evidence-based Complementary and Alternative Medicine
- Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine
- (2012) Hui-Ming Chen et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Vitamin E Analogue -TEA Stimulates Tumor Autophagy and Enhances Antigen Cross-Presentation
- (2012) Y. Li et al. CANCER RESEARCH
- T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
- (2012) A. Facciabene et al. CANCER RESEARCH
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Mammalian Target of Rapamycin Activator RHEB Is Frequently Overexpressed in Human Carcinomas and Is Critical and Sufficient for Skin Epithelial Carcinogenesis
- (2010) Z. H. Lu et al. CANCER RESEARCH
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo
- (2010) Jae-Beom Kim et al. PLoS One
- mTOR and cancer: many loops in one pathway
- (2009) Alejo Efeyan et al. CURRENT OPINION IN CELL BIOLOGY
- Dynamics of peripheral tolerance and immune regulation mediated by Treg
- (2009) Shimon Sakaguchi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
- (2009) Ethan M. Shevach IMMUNITY
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Regulatory T Cell-Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
- (2008) L. M. Ebert et al. CANCER RESEARCH
- Efficient Cross-presentation Depends on Autophagy in Tumor Cells
- (2008) Y. Li et al. CANCER RESEARCH
- Multiple Hsp70 Isoforms in the Eukaryotic Cytosol: Mere Redundancy or Functional Specificity?
- (2008) Mehdi Kabani et al. CURRENT GENOMICS
- Immunogenic cancer cell death: a key-lock paradigm
- (2008) Antoine Tesniere et al. CURRENT OPINION IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now